SK

Sanjay Kumar Khare

Active Director Designated Partner DIN 10654438
DIN 10654438 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Kumar Khare

Data last updated:

Sanjay Kumar Khare is a Designated Partner at S4 C2d Developers Llp (since 2024) and Designated Partner at Mscians Drugs India Llp (since 2024).

DIN 10654438
Primary Designation Designated Partner
First Appointment 03 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Aug 20242024Active
Designated Partner03 Jun 20242024Active

Board colleagues of Sanjay Kumar Khare

NameDINCompanyDesignation
Suresh Chandra Srivastava00966065S4 C2d Developers LlpDesignated Partner
Adity Sharma11219492Mscians Drugs India LlpDesignated Partner
Aryansh Khare10654440Mscians Drugs India LlpDesignated Partner
Sunita Shrivastava10654439Mscians Drugs India LlpDesignated Partner

Directorship timeline

Open interactive timeline →
S4 C2d Developers Llp
Mscians Drugs India Llp
Premium access

Shareholding and investment profile for Sanjay Kumar Khare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Khare

Sanjay Kumar Khare currently holds 2 directorships: S4 C2d Developers Llp (Designated Partner, since 20 Aug 2024); Mscians Drugs India Llp (Designated Partner, since 03 Jun 2024).

Sanjay Kumar Khare was first appointed on 03 Jun 2024 as Designated Partner at Mscians Drugs India Llp.

The current boards of Sanjay Kumar Khare's companies include Suresh Chandra Srivastava (S4 C2d Developers Llp), Adity Sharma (Mscians Drugs India Llp), Aryansh Khare (Mscians Drugs India Llp), Sunita Shrivastava (Mscians Drugs India Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available